Territorial Availability: Available through Bertin Technologies only in France
- Correlated keywords
- Escherichia JAK-2 Val-22 Cys-167 Met-1 OB Obese Protein Met-1
- Product Overview:
Leptin is a peptide hormone that regulates energy homeostasis, growth, and reproduction, as well as immune function.{60447} It is secreted by adipocytes and regulated by nutritional status, where fasting reduces leptin levels and feeding increases leptin levels, as well as in a circadian manner, with serum levels peaking at night.{60449,60450} Circulating leptin can bind leptin receptors expressed by peripheral immune cells, such as macrophages, natural (NK) cells, and B and T cells, or be transported across the blood brain barrier, where it binds to neuronally expressed leptin receptors.{60447} Binding of leptin to the leptin receptor induces the recruitment and phosphorylation of JAK2, leading to activation of a variety of intracellular signaling cascades, including MAPK-, STAT-, PI3K-, and AMPK-mediated pathways.{60449} Leptin-dependent signaling pathways promote energy expenditure, growth, and reproductive functions, reduce food intake and the production of adrenal corticosteroids, and enhance innate and adaptive immune responses.{60447} Leptin-deficient ob/ob mice exhibit severe obesity, hyperlipidemia, hyperglycemia, and hyperinsulinemia and are a commonly used model of obesity and type 2 diabetes.{60451} Serum leptin levels are increased in individuals with a variety of conditions, including obesity or insulin resistance.{60452} Cayman’s Leptin (human, recombinant) protein can be used for binding assays. The protein was synthesized from a DNA sequence encoding the mature form of human leptin (Val22-Cys167) with an N-terminal translation-initiating methionine (Met1). The expressed protein consists of 147 amino acids, has a calculated molecular weight of 16 kDa, and a predicted N-terminus of Met1.
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.